Melatonin Kent

Melatonin, the active ingredient in Melatonin Kent, is a melatonin receptor agonist presented as an oral supplement for oral use. It helps regulate the circadian rhythm and is used to manage sleep disorders such as insomnia, jet lag and delayed sleep phase disorder in adults and children.

GNH USA supplies Melatonin Kent as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin acts on the melatonin MT1 and MT2 receptors to support normal sleep‑wake cycles.

- Insomnia: helps reduce time to fall asleep and improves overall sleep quality. - Jet lag: assists the body in adjusting its internal clock after rapid time‑zone travel. - Delayed sleep phase disorder: promotes earlier sleep onset in individuals with a shifted circadian rhythm.

Melatonin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness - Headache - Dizziness - Nausea - Vivid dreams - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Allergic reaction (rash, itching, swelling, or difficulty breathing) - Severe hypotension or marked blood pressure drop - Mood changes such as depression, agitation, or anxiety - Unusual bleeding or bruising - Hallucinations or confusion in susceptible individuals

Melatonin should be used with awareness of specific safety considerations.

- Pregnancy: safety not established; avoid unless prescribed by a healthcare professional. - Breastfeeding: unknown safety profile; weigh potential risks against benefits. - Age: use caution in children and adolescents; dosing must be individualized by a clinician. - Drug interactions: review concomitant medications, especially sedatives and anticoagulants. - Medical conditions: exercise caution in patients with depression, seizure disorders, or severe hepatic impairment. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Melatonin can interact with several medication classes; monitoring is advised.

Major Interactions (Avoid): - Benzodiazepines: additive sedative effect may cause excessive drowsiness. - Antidepressants (SSRIs, MAOIs): increased risk of serotonin syndrome. - Anticoagulants: possible enhancement of bleeding tendency.

Moderate Interactions (Monitor Closely): - Caffeine: may diminish melatonin’s sleep‑promoting effect. - Alcohol: can amplify drowsiness and impair coordination. - Oral contraceptives: may raise plasma melatonin concentrations, requiring observation.